Skip to content
Research Article Open access CC BY 4.0

Synthesis and Characterization of Impurities of a Common and Advanced Intermediate of Candesartan and Azilsartan Antihypertensive Drugs

Sangeeta Sangwan, Tapas Panda, Kaushal Nayyar, Sharwan K. Dewan, Rajesh K. Thaper

International Research Journal of Pure and Applied Chemistry · pp. 140–149 · Published 6 Nov 2014

10.9734/IRJPAC/2015/13162

Abstract

Six impurities were identified in the lab development batches during the course of benzimidazole intermediate (1) synthesis by reverse phase HPLC method. Intermediate 1 is used as a common and advanced intermediate in the synthesis of candesartan and azilsartan. All the impurities were characterized by IR, NMR, LC/MS and CHN analyses, which included an isomer of intermediate 11 (impurity 19), desethyl analogue of 1 (impurity 20), desethoxy analogue of 1 (impurity 21), methyl analogue of 1 (impurity 22), cyanobiphenyl benzimidazole (impurity 25) and cyanobiphenyl derivative of 1 (impurity 26). The synthesis and characterization of these impurities are presented.

Candesartan azilsartan benzimidazole impurity API and intermediate

Cited by 2

Synthesis and characterization of related substances of Azilsartan Kamedoxomil

N. V. D. Harikiran Maddi, Srinivas Garaga, Ambati V. Raghava Reddy · Current Issues in Pharmacy and Medical Sciences · 2017

Identification of new process-related impurity in the key intermediate in the synthesis of TCV-116

Ana Testen, Miha Plevnik, Bogdan Štefane · Acta Pharmaceutica · 2018

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.